USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
BRAIN PLASTICITY, INC.
Address:
625 Market Street
Ste 610
SAN FRANCISCO, CA 94105-3302
Phone:
N/A
URL:
N/A
EIN:
127060033
DUNS:
831447730
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,580,121.00 4
SBIR Phase II $4,319,220.00 3

Award List:

Tonic and Phasic Alertness Training For the Treatment of Hemineglect

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$698,203.00
Agency:
HHS
Principal Investigator:
Thomas Vanvleet
Abstract:
DESCRIPTION (provided by applicant): The goal of the current project is to develop and test a computerized attention training program (TAPAT-ATT) to meet the needs of patients with hemispatial neglect following stroke or traumatic brain injury. As a group, these patients tend to have poorer… More

A computerized neuro-plasticity based training module to remediate social cogniti

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$498,004.00
Agency:
HHS
Principal Investigator:
Mor Nahum – 415-230-2745
Abstract:
DESCRIPTION (provided by applicant): The primary objective of this Phase I proposal is to develop and evaluate a novel, brain-based and web-deliverable multimedia training program targeting the treatment of social cognition deficits in schizophrenia. Social cognition impairments have been directly… More

Tonic and Phasic Alertness Training For Cognitive Decline in Aging

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$686,014.00
Agency:
HHS
Principal Investigator:
Thomas Vanvleet – 925-580-2806
Abstract:
DESCRIPTION (provided by applicant): The primary objective of this Phase I application is to develop and deploy a novel, neuroplasticity- based, computerized training program that has been shown to drive positive changes in attention, working memory and executive function in a vulnerable aging… More

Amplified Attention Training (AAT) for the Treatment of Hemispatial Nelgect

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$1,806,678.00
Agency:
HHS
Principal Investigator:
Thomas Vanvleet – 925-580-2806
Abstract:
DESCRIPTION (provided by applicant): The goal of the current project is to revise a prototype of a computerized attention training program (Amplified Attention Training, AAT) for hemispatial neglect completed in Phase I, and conduct a multi-site, randomized, controlled trial to establish efficacy in… More

Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$697,900.00
Agency:
HHS
Principal Investigator:
Hyun K. Lee – 319-400-7391
Abstract:
DESCRIPTION (provided by applicant): The primary objective of the current project is to develop and evaluate the efficacy of on-line brain plasticity-based computerized assessment tool and training program for the prevention and delay of the onset of Alzheimer's disease (AD). This novel… More

Amplified Attention Training (AAT) for Age-related Cognitive Decline

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,027,308.00
Agency:
HHS
Principal Investigator:
Thomas Vanvleet – 925-580-2806
Abstract:
DESCRIPTION (provided by applicant): The goal of the current project is to revise a prototype of a computerized attention training program (Memory Lane-Amplified Attention Training, M-AAT) designed for age-related cognitive decline completed in Phase I, and conduct a multi-site, randomized,… More

Computerized Social Cognition training for Schizophrenia

Award Year / Program / Phase:
2014 / SBIR / Phase II
Award Amount:
$1,485,234.00
Agency:
HHS
Principal Investigator:
Mor Nahum – 415-230-2745
Abstract:
DESCRIPTION (provided by applicant): The goal of the current project is to revise a prototype of a computerized, web-deliverable, social cognition training program (SocialVille) for schizophrenia completed in Phase I, and conduct a multi-site, randomized,controlled trial to establish efficacy in… More